Uncommon EGFR Exon 19 Mutations Confer Gefitinib Resistance in Advanced Lung Adenocarcinoma

被引：11
|
作者：
Coco, Simona [1 ]
Truini, Anna [1 ]
Vanni, Irene [1 ]
Genova, Carlo [1 ]
Rosano, Camillo [2 ]
Dal Bello, Maria Giovanna [1 ]
Alama, Angela [1 ]
Vene, Roberta [3 ]
Rijavec, Erika [1 ]
Barletta, Giulia [1 ]
Biello, Federica [1 ]
Boccardo, Francesco [4 ,5 ]
Grossi, Francesco [1 ]
机构：
[1] IRCCS AOU San Martino IST, Lung Canc Unit, Ist Nazl Ric Cancro, I-16132 Genoa, Italy
[2] IRCCS AOU San Martino IST, Biopolymers & Prote Unit, Ist Nazl Ric Cancro, I-16132 Genoa, Italy
[3] IRCCS AOU San Martino IST, Mol Oncol & Angiogenesis Unit, Ist Nazl Ric Cancro, I-16132 Genoa, Italy
[4] IRCCS AOU San Martino IST, Dipartimento Med Interna & Specialita Med DIMI, Ist Nazl Ric Cancro, I-16132 Genoa, Italy
[5] IRCCS AOU San Martino IST, UOC Clin Oncol Med, Ist Nazl Ric Cancro, I-16132 Genoa, Italy
来源：
JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 06期
关键词：
CANCER;
D O I：
10.1097/JTO.0000000000000538
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E50 / E52
页数：4
相关论文
共 50 条
  • [1] EGFR Exon 19 Insertions: A New Family of Sensitizing EGFR Mutations in Lung Adenocarcinoma
    He, Mai
    Capelletti, Marzia
    Nafa, Khedoudja
    Yun, Cai-Hong
    Arcila, Maria E.
    Miller, Vincent A.
    Ginsberg, Michelle S.
    Zhao, Binsheng
    Kris, Mark G.
    Eck, Michael J.
    Jaenne, Pasi A.
    Ladanyi, Marc
    Oxnard, Geoffrey R.
    [J]. CLINICAL CANCER RESEARCH, 2012, 18 (06) : 1790 - 1797
  • [2] First-line Osimertinib for Lung Cancer With Uncommon EGFR Exon 19 Mutations and EGFR Compound Mutations
    Cheunkarndee, Tia
    Guo, Matthew Z.
    Houseknecht, Stefanie
    Feliciano, Josephine L.
    Hann, Christine L.
    Lam, Vincent K.
    Levy, Benjamin P.
    Murray, Joseph C.
    Brahmer, Julie R.
    Forde, Patrick M.
    Marrone, Kristen A.
    Scott, Susan C.
    [J]. JTO CLINICAL AND RESEARCH REPORTS, 2024, 5 (06):
  • [3] EGFR Exon 19 Insertions in Lung Adenocarcinoma
    He, M.
    Nafa, K.
    Arcila, M.
    Brevet, M.
    Oxnard, G.
    Miller, V.
    Ladanyi, M.
    [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2009, 11 (06): : 655 - 655
  • [4] Efficacy of Osimertinib in Patients with Lung Cancer Positive for Uncommon EGFR Exon 19 Deletion Mutations
    Grant, Michael J.
    V. Aredo, Jacqueline
    Starrett, Jacqueline H.
    Stockhammer, Paul
    van Rosenburgh, Iris K. van Alderwerelt
    Wurtz, Anna
    Piper-Valillo, Andrew J.
    Piotrowska, Zofia
    Falcon, Christina
    Yu, Helena A.
    Aggarwal, Charu
    Scholes, Dylan
    Patil, Tejas
    Nguyen, Christina
    Phadke, Manali
    Li, Fang -Yong
    Neal, Joel
    Lemmon, Mark A.
    Walther, Zenta
    Politi, Katerina
    Goldberg, Sarah B.
    [J]. CLINICAL CANCER RESEARCH, 2023, 29 (11) : 2123 - 2130
  • [5] Differential Efficacy of Gefitinib in Exon 19 or Exon 21 Mutated Adenocarcinoma Lung
    Goe, Alok
    Joshi, Amit
    Patil, Vijay
    Noronha, Vanita
    Chougule, Anuradha
    Mahajan, Abhishek
    Janu, Amit
    Kaushal, Rajiv
    Goud, Supriya
    More, Sucheta
    Karpe, Ashay
    Ramaswamy, Anant
    Pande, Nikhil
    Chandrasekharan, Arun
    Talreja, Vikas
    Chanana, Raajit
    Prabhash, Kumar
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1189 - S1189
  • [6] Secondary Mutations of the EGFR Gene That Confer Resistance to Mobocertinib in EGFR Exon 20 Insertion
    Hamada, Akira
    Suda, Kenichi
    Nishino, Masaya
    Obata, Keiko
    Oiki, Hana
    Fukami, Tomoyo
    Fukuda, Shota
    Fujino, Toshio
    Ohara, Shuta
    Koga, Takamasa
    Chiba, Masato
    Shimoji, Masaki
    Ito, Masaoki
    Takemoto, Toshiki
    Soh, Junichi
    Tsutani, Yasuhiro
    Mitsudomi, Tetsuya
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (01) : 71 - 79
  • [7] Primary resistance to gefitinib in a patient with lung adenocarcinoma harboring an EGFR exon 19 L747-A750>P mutation
    Wei, Qiang
    Zhang, Jin
    Chen, Dongsheng
    Li, Si
    Liu, Yuanhua
    [J]. LUNG CANCER, 2020, 148 : 175 - 176
  • [8] Differential outcomes in patients with uncommon EGFR exon 19 mutations.
    Stewart, Tyler
    Truini, Anna
    DeVeaux, Michelle
    Zelterman, Daniel
    Walther, Zenta
    Wurtz, Anna
    Gettinger, Scott N.
    Politi, Katerina A.
    Goldberg, Sarah B.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [9] Lung Carcinomas with EGFR Exon 19 Insertions Are Sensitive to Gefitinib Treatment
    Iyevleva, Aglaya G.
    Mitiushkina, Natalia V.
    Karaseva, Nina A.
    Orlov, Sergey V.
    Volodina, Larisa N.
    Kulikova, Yulia E.
    Lozhkina, Alexandra M.
    Ivantsov, Alexandr O.
    Tiurin, Vladislav I.
    Togo, Alexandr V.
    Imyanitov, Evgeny N.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (04) : E31 - E33
  • [10] MOLECULAR HETEROGENEITY AND RESPONSE TO GEFITINIB OF EGFR MUTANT ADVANCED LUNG ADENOCARCINOMA
    Bria, E.
    Pilotto, S.
    Amato, E.
    Fassan, M.
    Novello, S.
    Vavala, T.
    Righi, L.
    Sperduti, I.
    Scarpa, A.
    Tortora, G.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (04) : S38 - S39
12345